Editorial Comment to Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study.
Saved in:
| Title: | Editorial Comment to Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study. |
|---|---|
| Authors: | Miyazawa Y; Department of Urology, Gunma University Graduate School of Medicine & Gunma University Hospital, Maebashi, Japan. |
| Source: | International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2026 May; Vol. 33 (5), pp. e70488. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
